Literature DB >> 23756265

The Human UDP-glucuronosyltransferase UGT2A1 and UGT2A2 enzymes are highly active in bile acid glucuronidation.

Martin Perreault1, Louis Gauthier-Landry, Jocelyn Trottier, Mélanie Verreault, Patrick Caron, Moshe Finel, Olivier Barbier.   

Abstract

Bile acids (BA) are essential modulators of lipid, glucose, and cholesterol homeostasis, but they exert cytotoxic effects in the cholestatic liver. Glucuronidation, catalyzed by the UDP-glucuronosyltransferase (UGT) enzymes is a pharmacologically relevant BA detoxification process. The present study characterized the BA-conjugating activity of the little-studied human UGTs of subfamily 2A: UGT2A1, 2A2, and 2A3. Recombinant UGT2As, expressed in baculovirus-infected insect cells, were assayed for the glucuronidation of six major bile acids: chenodeoxycholic acid (CDCA), cholic acid (CA), lithocholic acid (LCA), deoxycholic acid (DCA), hyocholic acid (HCA) and hyodeoxycholic acid (HDCA). UGT2A3 exhibited detectable but very low activity with all the tested BA substrates. UGT2A1 was highly efficient in forming LCA-3 and LCA-24G, CDCA-24, DCA-24, HCA-24, and HDCA-24G, whereas UGT2A2 was the most active enzyme for CA-24G and CDCA-24G formation and also was able to generate HDCA-6G, HDCA-24G, LCA-24G, and HCA-24G. The Km values of UGT2A1 varied between 102.2 ± 14.3 µM and 2.4 ± 1.2 mM. With the exception of CA-24G, a low affinity substrate for UGT2A2, all the Km values for UGT2A2 were in the 100 to 400 µM range. We demonstrate the high reactivity of the human UGT2A1 and UGT2A2 for bile acid glucuronidation. The physiologic importance of these reactions to BA disposition remains, however, to be clarified in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756265      PMCID: PMC3815633          DOI: 10.1124/dmd.113.052613

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  22 in total

1.  Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver.

Authors:  Jocelyn Trottier; Mélanie Verreault; Susan Grepper; Didier Monté; Julie Bélanger; Jenny Kaeding; Patrick Caron; Ted T Inaba; Olivier Barbier
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

2.  Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis.

Authors:  Ryan T Bushey; Gang Chen; Andrea S Blevins-Primeau; Jacek Krzeminski; Shantu Amin; Philip Lazarus
Journal:  Pharmacogenet Genomics       Date:  2011-02       Impact factor: 2.089

3.  Enzymatic production of bile Acid glucuronides used as analytical standards for liquid chromatography-mass spectrometry analyses.

Authors:  Patrick Caron; Jocelyn Trottier; Mélanie Verreault; Julie Bélanger; Jenny Kaeding; Olivier Barbier
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

4.  Glucuronidation of the steroid enantiomers ent-17β-estradiol, ent-androsterone and ent-etiocholanolone by the human UDP-glucuronosyltransferases.

Authors:  Nina Sneitz; Kathiresan Krishnan; Douglas F Covey; Moshe Finel
Journal:  J Steroid Biochem Mol Biol       Date:  2011-08-27       Impact factor: 4.292

Review 5.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 6.  Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential.

Authors:  Mélanie Verreault; Jenny Kaeding; Patrick Caron; Jocelyn Trottier; Laurent Grosse; Elise Houssin; Sophie Pâquet; Martin Perreault; Olivier Barbier
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

7.  The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.

Authors:  Katriina Itäaho; Peter I Mackenzie; Shin-ichi Ikushiro; John O Miners; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2008-08-21       Impact factor: 3.922

8.  The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.

Authors:  John O Miners; Peter I Mackenzie; Kathleen M Knights
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

9.  UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly.

Authors:  Taina Sten; Ingo Bichlmaier; Tiia Kuuranne; Antti Leinonen; Jari Yli-Kauhaluoma; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2008-11-20       Impact factor: 3.922

10.  Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate.

Authors:  J Trottier; P Caron; R J Straka; O Barbier
Journal:  Clin Pharmacol Ther       Date:  2011-06-29       Impact factor: 6.875

View more
  13 in total

1.  The influence of bile acids homeostasis by cryptotanshinone-containing herbs.

Authors:  Chengcheng Gao; Tianheng Ma; Liqun Pang; Rui Xie
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.

Authors:  Kathleen G Barrett; Hailin Fang; Daniela Cukovic; Alan A Dombkowski; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2015-05-06       Impact factor: 3.922

3.  Nicotine regulates the expression of UDP-glucuronosyltransferase (UGT) in humanized UGT1 mouse brain.

Authors:  Masaya Sakamoto; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Pharmacokinet       Date:  2015-05-07       Impact factor: 3.614

4.  PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis.

Authors:  Xueyan Zhou; Lijuan Cao; Changtao Jiang; Yang Xie; Xuefang Cheng; Kristopher W Krausz; Yunpeng Qi; Lu Sun; Yatrik M Shah; Frank J Gonzalez; Guangji Wang; Haiping Hao
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

5.  Global identification of microRNAs associated with chlorantraniliprole resistance in diamondback moth Plutella xylostella (L.).

Authors:  Bin Zhu; Xiuxia Li; Ying Liu; Xiwu Gao; Pei Liang
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

6.  Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions.

Authors:  Martin Perreault; Ewa Wunsch; Andrzej Białek; Jocelyn Trottier; Mélanie Verreault; Patrick Caron; Guy G Poirier; Piotr Milkiewicz; Olivier Barbier
Journal:  Can J Gastroenterol Hepatol       Date:  2018-04-11

7.  The evolution of UDP-glycosyl/glucuronosyltransferase 1E (UGT1E) genes in bird lineages is linked to feeding habits but UGT2 genes is not.

Authors:  Yusuke K Kawai; Yoshinori Ikenaka; Mayumi Ishizuka; Akira Kubota
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

8.  Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.

Authors:  Delores J Grant; Ani Manichaikul; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Lauren C Peres; Edward S Peters; Ann G Schwartz; Paul D Terry; Xin-Qun Wang; Temitope O Keku; Cathrine Hoyo; Andrew Berchuck; Dale P Sandler; Jack A Taylor; Katie M O'Brien; Digna R Velez Edwards; Todd L Edwards; Alicia Beeghly-Fadiel; Nicolas Wentzensen; Celeste Leigh Pearce; Anna H Wu; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Joseph H Rothstein; Francesmary Modugno; Roberta Ness; Kirsten Moysich; Mary Anne Rossing; Jennifer A Doherty; Thomas A Sellers; Jennifer B Permuth-Way; Alvaro N Monteiro; Douglas A Levine; Veronica Wendy Setiawan; Christopher A Haiman; Loic LeMarchand; Lynne R Wilkens; Beth Y Karlan; Usha Menon; Susan Ramus; Simon Gayther; Aleksandra Gentry-Maharaj; Kathryn L Terry; Daniel W Cramer; Ellen L Goode; Melissa C Larson; Scott H Kaufmann; Rikki Cannioto; Kunle Odunsi; John L Etter; Ruea-Yea Huang; Marcus Q Bernardini; Alicia A Tone; Taymaa May; Marc T Goodman; Pamela J Thompson; Michael E Carney; Shelley S Tworoger; Elizabeth M Poole; Diether Lambrechts; Ignace Vergote; Adriaan Vanderstichele; Els Van Nieuwenhuysen; Hoda Anton-Culver; Argyrios Ziogas; James D Brenton; Line Bjorge; Helga B Salvensen; Lambertus A Kiemeney; Leon F A G Massuger; Tanja Pejovic; Amanda Bruegl; Melissa Moffitt; Linda Cook; Nhu D Le; Angela Brooks-Wilson; Linda E Kelemen; Paul D P Pharoah; Honglin Song; Ian Campbell; Diana Eccles; Anna DeFazio; Catherine J Kennedy; Joellen M Schildkraut
Journal:  Cancer Med       Date:  2019-04-18       Impact factor: 4.711

9.  Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph-Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice.

Authors:  Francesca Ferlenghi; Carmine Giorgio; Matteo Incerti; Lorenzo Guidetti; Paola Chiodelli; Marco Rusnati; Massimiliano Tognolini; Federica Vacondio; Marco Mor; Alessio Lodola
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-28

10.  Chromosome Genome Assembly of Cromileptes altivelis Reveals Loss of Genome Fragment in Cromileptes Compared with Epinephelus Species.

Authors:  Yang Yang; Lina Wu; Zhuoying Weng; Xi Wu; Xi Wang; Junhong Xia; Zining Meng; Xiaochun Liu
Journal:  Genes (Basel)       Date:  2021-11-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.